Be cautious: New COVID-19 variant "Omicron" spreads to more countries

Company news

Scientists in South Africa on November 24, 2021, identified a concerning new variant of the coronavirus, whose mutations mark a "big jump in evolution" that is driving a spike in new cases. Hours later, Britain banned flights from six southern African nations, citing the variant. Later this variant was also detected in Botswana, Hong Kong, Italy, Israel, Australia, Germany, France, Switzerland, UK, Netherlands, Canada, Demark, Austria, Czech Republic, and Belgium…


The variant Omicron, also known as B.1.1.529, is primarily of concern due to the large number of mutations it has in the Spike gene. Many of these variants are in the binding receptor-binding domain and N-terminal domain, and thus may play key roles in ACE2 binding and antibody recognition, which might help it evade vaccines and make it more contagious.


Source: CoVariants


As previously announced by Bioperfectus, our PCR reagents products including (COVID–19 Coronavirus Real Time PCR Kit, COVID–19 Coronavirus (ORFlab/N/E) Real Time PCR Kit, COVID–19 Coronavirus and Influenza A/B Virus Real Time PCR Kit) stay effective in face of this new SARS-CoV-2 variant, B1.1.529.


At present, Bioperfectus has completed the data monitoring of all the mutant strains of SARS-CoV-2, Including Alpha (UK B.1.1.7), Beta (South Africa B.1.351), Gamma (Brazil P.1), Delta (India B.1.617.1, AY.1, AY.2, AY.3), Zeta (Brazil P.2), Eta (Britain/Nigeria B.1.525) Lambda (Peru C.37) and Fin-796H (Finland), N.9, B.1.616 (France), Epsilon B.1.1.529+ B.1.427 (USA), and P.3 (Theta Philippines), Mu (B.1.621).


The results of in silico analysis, pseudo-virus synthesis, and experimental verification on mutation sites confirmed that all Bioperfectus COVID-19 Real-time PCR reagents: COVID–19 Coronavirus Real-Time PCR Kit, COVID–19 Coronavirus (ORFlab/N/E) Real-Time PCR Kit, and  COVID–19 Coronavirus and Influenza A/B Virus Real-Time PCR Kit show no drop off in specificity, accuracy, and sensitivity of SARS-CoV-2 detection, and it will not miss the target and the detection for the above variant strains.


Bioperfectus Total COVID-19 Molecular Solution will make double assurance to the global pandemic fight. The solution provides validated systems which consist of nucleic acid extraction and PCR kit and compatible instruments. With different throughput instruments, the solution could meet various sample size detection demands. Using this solution, laboratories will get accurate results for COVID-19 samples with no missing known variants.


As the global pandemic remains severe and complicated, Bioperfectus is always following all variants of COVID-19 and other infectious diseases outbreak all around the world. Our R&D works to provide all diagnostic solution and will release new products once it fulfills the clinical and regulatory requirements.


For more information regarding COVID-19 variants, please feel free to contact us via,


Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.


Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.


Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).